Standard Operating Procedure for Country-Specific Label Adaptation and Approval
| Department | Regulatory Affairs |
| SOP No. | RA/2026/748 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 15/04/2026 |
| Effective Date | 15/04/2026 |
| Review Date | 15/04/2028 |
Purpose
This Standard Operating Procedure (SOP) outlines the systematic approach for adapting and obtaining approval for product labels specific to different countries. It ensures timely, compliant, and controlled modifications to labeling and artwork to meet country-specific regulatory requirements, thereby supporting product registration, market authorization, and adherence to global quality and regulatory standards.
Scope
This SOP applies to all Regulatory Affairs personnel involved in label and artwork adaptation activities for pharmaceutical products. It covers all dosage forms and finished products intended for distribution in international markets requiring country-specific label changes. The SOP governs activities from receiving country-specific requirements through final approval and release of labeling materials. This SOP excludes manufacturing operations, printing processes, and distribution activities outside regulatory adaptation scope.
Responsibilities
- Regulatory Affairs Specialist: Executes label adaptation and prepares submission dossiers.
- Regulatory Affairs Manager: Reviews, approves, and ensures compliance with regulatory requirements.
- Quality Assurance: Oversees compliance verification and documentation control.
- Artwork/Labeling Team: Implements the required changes to artwork and labeling layouts based on regulatory input.
- Document Control: Maintains controlled master copies of all adapted labels and associated documentation.
Accountability
The Regulatory Affairs Head is accountable for the overall implementation, compliance, periodic review, escalation of issues, and continuous effectiveness of this SOP, ensuring all country-specific label adaptations meet applicable regulatory and quality requirements.
Procedure
1. Preparation and Prerequisites: Regulatory Affairs receives country-specific label requirements from health authorities, regulatory intelligence, or marketing teams. Confirm receipt of current master label and artwork files. Verify accessibility to latest regulatory guidelines and internal quality standards.
2. Initial Assessment: Review regulatory requirements, including language, content, graphic changes, warnings, and mandatory statements. Identify discrepancies, omissions, or conflicts with existing labels.
3. Label Adaptation Planning: Schedule adaptations factoring in submission timelines and manufacturing lead times. Communicate timelines and resource needs to Artwork and QA teams.
4. Execution of Adaptation: Instruction is passed to the Artwork/Labeling Team to implement required changes. Ensure usage of approved templates and control versioning strictly. Confirm all textual and graphical elements comply with country-specific mandates and internal style guides.
5. In-Process Controls and Quality Checks: The adapted artwork undergoes internal quality checks, including linguistic accuracy, regulatory compliance, legibility, and trademark considerations. QA reviews the draft label thoroughly for errors and omissions.
6. Verification and Approvals: Submit the adapted labels for approval by Regulatory Affairs Manager and Quality Assurance. Obtain documented approvals before submission.
7. Submission to Authorities: Regulatory Affairs submits adapted labels as part of regulatory dossiers or change supplements with required justification and supporting documentation.
8. Record Keeping and Documentation: Archive all versions of label adaptations, approval records, correspondence, and submission documents in controlled document management systems. Ensure records are retained as per regulatory requirements.
9. Handling Deviations: Any deviation or change identified post-approval must be documented via deviation forms and managed according to Quality Management System procedures.
10. Closure and Periodic Review: Upon completion of approval and implementation, update status in relevant tracking systems. Conduct periodic reviews of SOP effectiveness and compliance with evolving regulatory requirements.
Abbreviations
- SOP: Standard Operating Procedure
- RA: Regulatory Affairs
- QA: Quality Assurance
- GMP: Good Manufacturing Practice
- Lbl: Label
- Art: Artwork
Documents
- Country-Specific Label Adaptation Request Form (Annexure-1)
- Label Adaptation Change Control Form (Annexure-2)
- Label Approval Record Sheet (Annexure-3)
References
- International Council for Harmonisation (ICH) Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
- Food and Drug Administration (FDA) Guidance on Labeling and Artwork Change Control
- EMA Guidelines on the labeling of medicinal products
- Pharmacopoeial labeling requirements specific to marketed products
- Internal Quality Management System documentation
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Country-Specific Label Adaptation Request Form
| Form Title: | Country-Specific Label Adaptation Request Form |
| Purpose: | To formally request label adaptation for specific country requirements ensuring traceability of request origin and details. |
| Field | Details / Example |
|---|---|
| Request Date | 10/03/2026 |
| Product Name | Product ABC Tablets |
| Dosage Form | Tablet |
| Country | Brazil |
| Regulatory Requirement Summary | Include Portuguese language, insert new warning statement per ANVISA guidelines. |
| Requested By | Marketing Department |
| Signature | __________________ |
Annexure-2: Label Adaptation Change Control Form
| Form Title: | Label Adaptation Change Control Form |
| Purpose: | To control and document all changes made to labels during country-specific adaptations ensuring traceability and compliance to GMP. |
| Field | Details / Example |
|---|---|
| Change Control No. | CC-2026-045 |
| Date Initiated | 12/03/2026 |
| Product | Product ABC Tablets |
| Description of Change | Adding mandatory country-specific caution statements and translating label text to Portuguese. |
| Reason for Change | Regulatory compliance per ANVISA update. |
| Affected Documents | Artwork files, Label master file |
| Initiated By | Regulatory Affairs Specialist |
| Reviewed By | Quality Assurance |
| Approved By | Regulatory Affairs Manager |
| Implementation Date | 20/03/2026 |
Annexure-3: Label Approval Record Sheet
| Form Title: | Label Approval Record Sheet |
| Purpose: | To document all relevant approvals for adapted labels before release and use in the market. |
| Field | Details / Example |
|---|---|
| Label Version Number | V2.3_BR |
| Product Name | Product ABC Tablets |
| Country | Brazil |
| Date Submitted for Approval | 18/03/2026 |
| Regulatory Affairs Approval | Approved, Date: 19/03/2026, Signature: __________ |
| Quality Assurance Approval | Approved, Date: 19/03/2026, Signature: __________ |
| Final Approval and Release | Released for printing, Date: 20/03/2026, Signature: __________ |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 15/04/2026 | 1.0 | Initial issue | New SOP creation |